Welcome to our
Cross-Regional Pitch & Match session:
Next generation vaccines & immunotherapy
The objective of this event is to connect important actors in the field of immunology, vaccinology, oncology and immunotherapy from Flanders and Wallonia or even abroad.
Topic addressed?
The topic of the event is Next generation vaccines & immunotherapy, highlighting advances and innovations in recent vaccine and immunotherapy development. Vaccine platform technologies, broad-spectrum vaccines, new biomarker identification tools, better vaccine delivery systems, etc. will all help to prevent us from existing and future emerging pathogens. But also approved immune checkpoint inhibitors (ICIs) and cellular therapies like chimeric antigen receptor (CAR) T cells and tumor-infiltrating lymphocyte (TIL) therapy, as well as other modalities, such as oncolytic virus therapy are driving the next generation of immunotherapies for oncology, immune disorders and rare diseases.
During this networking afternoon, high quality presentations, including an informative talk of VLAIO/SPW/Innoviris explaining the interregional R&D collaboration programme BELCOO, and pitches of our member network will be followed by a B2B partnering session.
This means that presenters can directly harvest the fruits of their talk or pre-schedule meetings with potential partners via the networking tool - powered by B2Match!
We’re looking forward to meet you at this occasion and don’t hesitate to contact us if you have any questions.
